Legal & General Group Plc Buys 43,169 Shares of Danaher Corporation $DHR

Legal & General Group Plc lifted its holdings in shares of Danaher Corporation (NYSE:DHR) by 1.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 4,495,287 shares of the conglomerate’s stock after purchasing an additional 43,169 shares during the period. Legal & General Group Plc’s holdings in Danaher were worth $1,029,061,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. JPL Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter valued at $25,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher during the 4th quarter valued at $26,000. WFA of San Diego LLC bought a new position in shares of Danaher during the 2nd quarter valued at $26,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Danaher during the 3rd quarter valued at $27,000. Finally, Financial Life Planners bought a new position in shares of Danaher during the 3rd quarter valued at $32,000. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. Wolfe Research dropped their price target on shares of Danaher from $260.00 to $230.00 and set an “outperform” rating for the company in a research report on Wednesday, April 8th. Evercore increased their price target on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research report on Tuesday, April 21st. Barclays dropped their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. The Goldman Sachs Group dropped their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Monday, April 13th. Finally, Robert W. Baird dropped their price target on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research report on Friday, April 17th. Nineteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $238.65.

Danaher Trading Up 0.1%

NYSE:DHR opened at $172.12 on Monday. The company has a 50-day moving average price of $183.52 and a 200-day moving average price of $208.70. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The stock has a market cap of $121.82 billion, a price-to-earnings ratio of 33.29, a P/E/G ratio of 2.30 and a beta of 0.81.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period last year, the company posted $1.88 EPS. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. Equities analysts predict that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.